Use of Oxybutynin to Treat Axillary Hyperhidrosis

Status Completed

Clinical Trial Summary

The objective of this study was to evaluate the effectiveness and patient satisfaction with the use of oxybutynin at low doses for treating axillary hyperhidrosis in a large series of patients.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01118429
Study type	Interventional
Source	Grupo de Cirurgia Vascular
Contact
Status	Completed
Phase	N/A
Start date	January 2007
Completion date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546438` - Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis	N/A
Completed	`NCT03836287` - Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)	Phase 3
Enrolling by invitation	`NCT02105753` - Tx Axillary Hyperhidrosis 1210nm Diode Laser	N/A
Withdrawn	`NCT05546710` - miraDry Post Market Tumescent Anesthesia Study	N/A
Active, not recruiting	`NCT02295891` - Miradry Treatment for Focal Axillary Hyperhidrosis	N/A
Completed	`NCT01091129` - Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis	N/A
Completed	`NCT03948646` - Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)	Phase 3
Completed	`NCT01274611` - Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)	N/A
Completed	`NCT03320096` - Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis	N/A
Completed	`NCT00735293` - VASER Treatment of Axillary Hyperhidrosis/Bromidrosis	Phase 4